These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1218 related items for PubMed ID: 16569492

  • 1. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
    Broekhuizen LN, Wijsman JH, Peterse JL, Rutgers EJ.
    Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
    [Abstract] [Full Text] [Related]

  • 2. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
    Rydén L, Chebil G, Sjöström L, Pawlowski R, Jönsson PE.
    Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
    [Abstract] [Full Text] [Related]

  • 3. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry.
    Chagpar A, Middleton LP, Sahin AA, Meric-Bernstam F, Kuerer HM, Feig BW, Ross MI, Ames FC, Singletary SE, Buchholz TA, Valero V, Hunt KK.
    Cancer; 2005 Apr 15; 103(8):1581-6. PubMed ID: 15747375
    [Abstract] [Full Text] [Related]

  • 4. Incidence and clinical significance of lymph node metastasis detected by cytokeratin immunohistochemical staining in ductal carcinoma in situ.
    El-Tamer M, Chun J, Gill M, Bassi D, Lee S, Hibshoosh H, Mansukhani M.
    Ann Surg Oncol; 2005 Mar 15; 12(3):254-9. PubMed ID: 15827818
    [Abstract] [Full Text] [Related]

  • 5. The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up.
    Lara JF, Young SM, Velilla RE, Santoro EJ, Templeton SF.
    Cancer; 2003 Nov 15; 98(10):2105-13. PubMed ID: 14601079
    [Abstract] [Full Text] [Related]

  • 6. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
    Langer I, Guller U, Viehl CT, Moch H, Wight E, Harder F, Oertli D, Zuber M.
    Ann Surg Oncol; 2009 Dec 15; 16(12):3366-74. PubMed ID: 19760047
    [Abstract] [Full Text] [Related]

  • 7. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
    Altinyollar H, Kapucuoglu N, Pak I, Berberoglu U.
    J Exp Clin Cancer Res; 2000 Jun 15; 19(2):141-4. PubMed ID: 10965808
    [Abstract] [Full Text] [Related]

  • 8. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
    Barth A, Craig PH, Silverstein MJ.
    Cancer; 1997 May 15; 79(10):1918-22. PubMed ID: 9149018
    [Abstract] [Full Text] [Related]

  • 9. Validation of axillary sentinel lymph node detection in the staging of early lobular invasive breast carcinoma: a prospective study.
    Classe JM, Loussouarn D, Campion L, Fiche M, Curtet C, Dravet F, Pioud R, Rousseau C, Resche I, Sagan C.
    Cancer; 2004 Mar 01; 100(5):935-41. PubMed ID: 14983488
    [Abstract] [Full Text] [Related]

  • 10. The role of sentinel node biopsy in ductal carcinoma in situ of the breast.
    Polom K, Murawa D, Wasiewicz J, Nowakowski W, Murawa P.
    Eur J Surg Oncol; 2009 Jan 01; 35(1):43-7. PubMed ID: 18723312
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE, Vezeridis MP, Konstadoulakis M, Cole BF, Wanebo HJ, Bland KI.
    J Am Coll Surg; 1996 Dec 01; 183(6):575-82. PubMed ID: 8957459
    [Abstract] [Full Text] [Related]

  • 12. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
    Moore KH, Sweeney KJ, Wilson ME, Goldberg JI, Buchanan CL, Tan LK, Liberman L, Turner RR, Lagios MD, Cody Iii HS, Giuliano AE, Silverstein MJ, Van Zee KJ.
    Ann Surg Oncol; 2007 Oct 01; 14(10):2911-7. PubMed ID: 17597346
    [Abstract] [Full Text] [Related]

  • 13. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
    Sakr R, Barranger E, Antoine M, Prugnolle H, Daraï E, Uzan S.
    J Surg Oncol; 2006 Oct 01; 94(5):426-30. PubMed ID: 16967457
    [Abstract] [Full Text] [Related]

  • 14. Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma.
    Sakr R, Antoine M, Barranger E, Dubernard G, Salem C, Daraï E, Uzan S.
    Breast J; 2008 Oct 01; 14(1):55-60. PubMed ID: 18186866
    [Abstract] [Full Text] [Related]

  • 15. Distinction between isolated tumor cells and micrometastases in breast cancer: is it reliable and useful?
    de Mascarel I, MacGrogan G, Debled M, Brouste V, Mauriac L.
    Cancer; 2008 Apr 15; 112(8):1672-8. PubMed ID: 18286534
    [Abstract] [Full Text] [Related]

  • 16. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
    Meijnen P, Oldenburg HS, Loo CE, Nieweg OE, Peterse JL, Rutgers EJ.
    Br J Surg; 2007 Aug 15; 94(8):952-6. PubMed ID: 17440955
    [Abstract] [Full Text] [Related]

  • 17. The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases.
    Gipponi M, Canavese G, Lionetto R, Catturich A, Vecchio C, Sapino A, Friedman D, Cafiero F.
    Eur J Surg Oncol; 2006 Mar 15; 32(2):143-7. PubMed ID: 16300921
    [Abstract] [Full Text] [Related]

  • 18. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
    Torrenga H, Fabry H, van der Sijp JR, van Diest PJ, Pijpers R, Meijer S.
    J Surg Oncol; 2004 Oct 01; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
    [Abstract] [Full Text] [Related]

  • 19. Impact of CD44+CD24- cells on non-sentinel axillary lymph node metastases in sentinel node-positive breast cancer.
    Nogi H, Suzuki M, Kamio M, Kato K, Kawase K, Toriumi Y, Takeyama H, Fukushima H, Morikawa T, Uchida K.
    Oncol Rep; 2011 Apr 01; 25(4):1109-15. PubMed ID: 21308353
    [Abstract] [Full Text] [Related]

  • 20. Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up.
    Takeshita T, Tsuda H, Moriya T, Yamasaki T, Asakawa H, Ueda S, Sato K, Aida S, Tamai S, Matsubara O, Hase K, Yamamoto J.
    Ann Surg Oncol; 2012 Apr 01; 19(4):1160-6. PubMed ID: 21989659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.